Intimation by Material Subsidiary on the Investment
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures' material subsidiary, Time Medical International Ventures (India) Pvt Ltd, has approved a USD 12.5 million (approximately ₹104 crore) investment to acquire a 15% stake in M/s. Nanomedic Technologies and Solutions Pte Limited, a Singapore-based company. The target firm works in bio-medical therapeutics and specialises in its 'Spincare System' platform for advanced wound treatment, but was only incorporated in FY 2024-25 and has no turnover yet. The deal is a full cash consideration, not a related-party transaction, and is aimed at diversifying and expanding the group's business into wound-care technology. No specific regulatory approvals or completion timeline have been disclosed.
For shareholders, this signals a meaningful international diversification move into the medtech/wound-care space, though the target is very early-stage with no revenue. The deal size is sizeable relative to a small-cap listed entity, so execution risk and future funding needs for the Singapore subsidiary will be key things to watch.